In 2013, we1 surveyed leading US academic medical centers (AMCs) and found variability in lung cancer screening (LCS) practices. Since then, favorable policy and payment decisions have been announced by the US Preventive Services Task Force (USPSTF)2 and Centers for Medicare and Medicaid Services (CMS),3 and radiology-specific nodule guidelines have been established by the American College of Radiology (ACR).4 We resurveyed these same leading AMCs in 2014 and 2015 to reassess their practices and hypothesized that there would be greater conformity of practice patterns and increased patient volumes in response to these developments.
Boiselle PM, Chiles C, Ravenel JG, White CS. Computed Tomographic Screening for Lung Cancer Trends at Leading Academic Medical Centers From 2013 to 2015. JAMA Oncol. 2016;2(5):682-684. doi:10.1001/jamaoncol.2015.6419